Submitted by Anonymous (not verified) on 28 January 2026 - 12:54
Human medicines European public assessment report (EPAR): Movymia, teriparatide, Date of authorisation: 11/01/2017, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Movymia, teriparatide, Date of authorisation: 11/01/2017, Revision: 12, Status: Authorised